ENTX - CIK 0001638097
Entera Bio Ltd. (ENTX) reported net income of -$11.44M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$11.44M | -19.9% |
| FY 2024 | -$9.54M | -7.3% |
| FY 2023 | -$8.89M | +32.0% |
| FY 2022 | -$13.07M | -7.3% |
| FY 2021 | -$12.19M | -8.7% |
| FY 2020 | -$11.22M | - |
Entera Bio Ltd. (ENTX) reported net income of -$11.44M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Entera Bio Ltd.'s net income declined from -$11.22M to -$11.44M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.